Open AccessValidation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer
Author(s) -
Anil Vachani,
YuNing Wong,
Jennifer Israelite,
Nandita Mitra,
Sakhena Hin,
Lin Yang,
Aaron SmithMcLallen,
Katrina Armstrong,
Peter W. Groeneveld,
Andrew J. Epstein
Publication year - 2017
Publication title -
medical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.632
H-Index - 178
eISSN - 1537-1948
pISSN - 0025-7079
DOI - 10.1097/mlr.0000000000000484
Subject(s) - medicine , colorectal cancer , lung cancer , cancer , current procedural terminology , oncology , kras , mutation , algorithm , surgery , gene , biology , computer science , genetics
Targeted therapy for patients with lung and colon cancer based on tumor molecular profiles is an important cancer treatment strategy, but the impact of gene mutation tests on cancer treatment and outcomes in large populations is not clear. In this study, we assessed the accuracy of an algorithm to identify tumor mutation testing in administrative claims data during a period before test-specific Current Procedural Terminology codes were available.